Lung adenocarcinoma observation group:None

2 trials

Sponsors

Hunan Provincial People's Hospital, First Affiliated Hospital of Kunming Medical University

Conditions

Drug resistance of lung adenocarcinoma after immunotherapyLung adenocarcinoma

Unknown Phase

Profilin 1 induces immunotherapy resistance through promoting autophagic degradation of MHC-I in non-small cell lung cancer

Active, not recruitingChiCTR2500106979

Hunan Provincial People's HospitalDrug resistance of lung adenocarcinoma after immunotherapy

Start: 2025-08-01Updated: 2025-08-18

Complement factor B inhibits the progression of lung adenocarcinoma and the remodeling of the immune microenvironment by regulating the FOS-tryptophan metabolic axis.

Active, not recruitingChiCTR2600121212

First Affiliated Hospital of Kunming Medical UniversityLung adenocarcinoma

Start: 2026-03-26Updated: 2026-03-30